Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity
US7358250B2 · kind B2 · utility
3Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2005 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Jun 29, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds that modulate the action of ACK1 and LCK, and related compositions methods for treating ACK1- and LCK-mediated diseases are described. In one aspect, the compounds have the general structure:where the values of the substituents are provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.